Human pluripotent stem cell-derived cardiomyocytes as a target platform for paracrine protection by cardiac mesenchymal stromal cells

• Published in: Scientific reports 2020-08, Vol.10 (1), p.13016-13016, Article 13016
• Main Authors: Constantinou, Chrystalla, Miranda, Antonio M. A., Chaves, Patricia, Bellahcene, Mohamed, Massaia, Andrea, Cheng, Kevin, Samari, Sara, Rothery, Stephen M., Chandler, Anita M., Schwarz, Richard P., Harding, Sian E., Punjabi, Prakash, Schneider, Michael D., Noseda, Michela
• Format: Article
• Language: English
• Subjects: 631/532/2064/2158; 692/4019/592/2725; 692/4019/592/75; Animals; Apoptosis; Cardiac muscle; Cardiomyocytes; Cell culture; Coculture Techniques; Congestive heart failure; Coronary artery disease; Culture Media, Conditioned; Exosomes; Fibroblasts; Heart transplantation; Humanities and Social Sciences; Humans; Ischemia; Membrane potential; Mesenchymal stem cells; Mesenchymal Stem Cells - cytology; Mesenchyme; Mice; Mitochondria; multidisciplinary; Myocytes, Cardiac - cytology; Paracrine signalling; Pluripotency; Pluripotent Stem Cells - cytology; Science; Science (multidisciplinary); Secretome; Stem cells; Stromal cells; Stromal Cells - cytology
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-69495-w

Ischemic heart disease remains the foremost cause of death globally, with survivors at risk for subsequent heart failure. Paradoxically, cell therapies to offset cardiomyocyte loss after ischemic injury improve long-term cardiac function despite a lack of durable engraftment. An evolving consensus, inferred preponderantly from non-human models, is that transplanted cells benefit the heart via early paracrine signals. Here, we tested the impact of paracrine signals on human cardiomyocytes, using human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) as the target of mouse and human cardiac mesenchymal stromal cells (cMSC) with progenitor-like features. In co-culture and conditioned medium studies, cMSCs markedly inhibited human cardiomyocyte death. Little or no protection was conferred by mouse tail tip or human skin fibroblasts. Consistent with the results of transcriptomic profiling, functional analyses showed that the cMSC secretome suppressed apoptosis and preserved cardiac mitochondrial transmembrane potential. Protection was independent of exosomes under the conditions tested. In mice, injecting cMSC-conditioned media into the infarct border zone reduced apoptotic cardiomyocytes > 70% locally. Thus, hPSC-CMs provide an auspicious, relevant human platform to investigate extracellular signals for cardiac muscle survival, substantiating human cardioprotection by cMSCs, and suggesting the cMSC secretome or its components as potential cell-free therapeutic products.